NCT01585428 2018-03-07Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated CancersNational Institutes of Health Clinical Center (CC)Phase 2 Completed29 enrolled 12 charts